Surgical Sealants and Adhesives Market Size & Growth Forecast 2026–2035, By Segments (Type, Indication, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Surgical Sealants and Adhesives Market size was more than USD 3.03 Billion in 2025 and is set to grow at a 11.7% CAGR between 2026 and 2035, reaching USD 9.16 Billion by 2035. The industry revenue for 2026 is assessed at USD 3.34 billion.
Get more details on this report
Request Free Sample ReportSurgical Sealants and Adhesives Market Intelligence Snapshot
Regional Market Dynamics
- North America leads because of its established surgical infrastructure, broad adoption of advanced wound closure products, and mature procurement systems supporting routine use in hospitals.
- Asia Pacific is expected to expand at a 13.1% CAGR as rising surgical volumes, healthcare capacity expansion, and wider adoption of modern closure materials increase product utilization across developing healthcare systems.
Segment Momentum
- Natural or Biological Adhesives and Sealants held a 63.05% share in 2025 because they are widely integrated into surgical workflows, offering dependable tissue compatibility and familiar sealing performance in routine procedures.
- Tissue Engineering is expanding fastest as demand grows for advanced tissue repair and regenerative applications, increasing the need for sealants and adhesives designed for more complex biological repair environments.
Market Expansion Drivers
- Rising global surgical procedure volumes increasing demand for advanced tissue sealing products.
- Technological advancements in biological adhesives improving surgical safety and wound management outcomes.
- Increasing trauma and accident-related surgeries expanding usage of surgical sealants in emergency care.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Major companies in the surgical sealants and adhesives market include Johnson & Johnson (United States), Medtronic plc (Ireland), Baxter International Inc. (United States), Becton, Dickinson and Company (United States), B. Braun SE (Germany), Terumo Corporation (Japan), Integra LifeSciences Holdings Corporation (United States), Stryker Corporation (United States), Artivion, Inc. (United States), Cardinal Health, Inc. (United States).Regional and Segment Outlook
North AmericaMarket Growth Drivers and Industry Trends
As procedure volumes rise across general surgery, orthopedics, cardiovascular interventions, and minimally invasive operations, hospitals are handling more cases where reliable hemostasis, leak prevention, and tissue reinforcement directly affect operating efficiency and post-surgical management. This is driving demand for the surgical sealants and adhesives market because surgeons increasingly adopt adjunct closure products in cases where sutures and staples alone may prolong closure time or provide less effective sealing in delicate or high-fluid environments. Procurement patterns also shift as health systems standardize advanced sealing products for higher-throughput surgical departments, aiding market expansion through routine rather than limited-case use.
Technological advancements in biological adhesives improving surgical safety and wound management outcomes
Innovation in biologically derived formulations is reshaping product selection in the surgical sealants and adhesives market by improving biocompatibility, adhesion performance, controlled degradation, and ease of application in complex surgical fields. These advances influence market adoption when surgeons gain access to products that can reduce leakage, manage bleeding more precisely, and perform effectively on difficult tissues where conventional closure methods are less dependable. Product differentiation is becoming more clinically meaningful, prompting hospitals and surgical centers to favor newer adhesives that align with risk-reduction goals, particularly in procedures where wound healing quality and complication avoidance strongly influence treatment decisions.
Increasing trauma and accident-related surgeries expanding usage of surgical sealants in emergency care
A higher volume of trauma-related interventions increases the need for rapid, effective closure tools that can support bleeding control and tissue sealing under time-sensitive conditions. In emergency and acute care settings, the surgical sealants and adhesives market benefits from clinician preference for products that can be deployed quickly during complex repairs, especially when injuries involve irregular wounds, vascular damage, or internal tissue disruption that complicates conventional closure. This practical role in stabilizing patients during urgent surgery is increasing market adoption in trauma centers, where product availability and familiarity often shape repeat usage in high-pressure operating environments.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising global surgical procedure volumes increasing demand for advanced tissue sealing products | 2.20% | High | North America, Asia Pacific | High | Near Term |
| Technological advancements in biological adhesives improving surgical safety and wound management outcomes | 1.90% | Moderate | Europe, North America | High | Mid Term |
| Increasing trauma and accident-related surgeries expanding usage of surgical sealants in emergency care | 1.50% | Moderate | Asia Pacific, Africa | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America held the largest regional share of the surgical sealants and adhesives market in 2025, supported by established surgical care infrastructure and broad use of advanced wound closure products across hospital settings. The region’s leadership is reinforced by higher procedure volumes in complex surgeries where sealants and adhesives are used to control leakage, support hemostasis, and reduce reliance on conventional suturing in specific applications. Market activity is also sustained by the routine availability of specialized surgical products through mature procurement channels and the presence of clinicians familiar with adopting adjunct closure technologies in operating room practice.
Asia Pacific is projected to expand at a 13.1% CAGR over the forecast period in the surgical sealants and adhesives market, driven by rising surgical volumes and wider adoption of modern closure materials across developing healthcare systems. Growth is accelerating as hospitals increase access to specialty procedures and integrate products that can improve operative efficiency and post-surgical management in areas where case throughput is becoming more important. Demand is also being fueled by ongoing healthcare capacity expansion, which is bringing more patients into treated surgical pathways and increasing practical use of sealants and adhesives in both established urban centers and advancing secondary care markets.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Surgery SupportGermany emphasizes surgical sealants and adhesives that complement precision surgical techniques and specialized procedures. Demand is concentrated on clinically validated products that support tissue management and reduce complications in high-acuity care settings.
France 🇫🇷
Clinical Performance EmphasisFrance prioritizes surgical sealants and adhesives with demonstrated efficacy and compatibility across multiple surgical disciplines. Procurement decisions increasingly favor products that can support reduced complications and optimize resource utilization in hospitals.
Italy 🇮🇹
Specialized Surgery DemandItaly's market is driven by demand from cardiovascular and orthopedic specialties that require effective tissue sealing solutions. Hospitals are gradually integrating advanced adhesives to improve surgical workflows and address increasingly complex procedures.
Japan 🇯🇵
Aging Care ApplicationsJapan's aging population is increasing the use of surgical sealants and adhesives in cardiovascular, orthopedic, and general surgical interventions. Healthcare providers are seeking products that aid recovery and support efficient postoperative management.
South Korea 🇰🇷
Advanced Procedure ExpansionSouth Korea is incorporating surgical sealants and adhesives into expanding minimally invasive and reconstructive surgical practices. The market shows growing interest in bio-based formulations that improve precision and enhance procedural efficiency.
United States 🇺🇸
Procedure Innovation AdoptionThe U.S. market for surgical sealants and adhesives is supported by high adoption of advanced wound closure technologies in minimally invasive and complex procedures. Hospitals are increasingly evaluating products that reduce operating time and improve post-surgical outcomes.
Segment Leadership and Growth Trends
Surgical Sealants and Adhesives Market Share (%), Type, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportNatural or Biological Adhesives and Sealants held the strongest position in the surgical sealants and adhesives market in 2025, accounting for a 63.05% share. Their continued leadership is closely tied to established use in surgical settings where compatibility with tissue and routine integration into procedural workflows matter most. In the surgical sealants and adhesives market, this segment benefits from broad clinical familiarity and sustained preference in applications where dependable sealing performance must align with practical intraoperative use.
Synthetic and Semi Synthetic Adhesives and Sealants represent the fastest-growing segment in the surgical sealants and adhesives market as healthcare providers seek materials that can better address evolving procedural requirements. Their momentum is being reinforced through rising demand for more tailored performance characteristics across varied surgical applications, making them increasingly attractive where conventional options may offer less flexibility. Growth is outpacing alternatives because this segment aligns well with the need for application-specific sealing and adhesion in modern surgical practice.
Indication Segment Analysis: Tissue Sealing (Largest Segment) vs Tissue Engineering (Fastest-Growing Segment)
By indication, Tissue Sealing led the surgical sealants and adhesives market in 2025 with a 42.72% share. Its leadership reflects the core role of sealing in routine surgical care, where controlling leaks and supporting closure remain practical and recurring requirements across a wide range of procedures. The surgical sealants and adhesives market continues to see steady demand from this segment because it addresses an immediate operative need that is directly tied to surgical efficiency and outcome management.
Tissue Engineering is the fastest-growing indication in the surgical sealants and adhesives market, influenced by increasing interest in solutions that support more advanced tissue repair and regenerative applications. The segment is seeing wider adoption because it fits emerging clinical needs that extend beyond conventional closure, creating new demand for adhesives and sealants that can function within more complex biological repair environments. Its stronger growth relative to traditional indications comes from this expanding use case base rather than from established procedural volume.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Type | Natural or Biological Adhesives and Sealants, Synthetic and Semi Synthetic Adhesives and Sealants | Natural or Biological Adhesives and Sealants | Synthetic and Semi Synthetic Adhesives and Sealants |
| Indication | Tissue Sealing, Tissue Engineering, Hemostasis | Tissue Sealing | Tissue Engineering |
| Application | Central Nervous System, Cardiovascular, General Surgery, Orthopedic, Cosmetic, Pulmonary, Urology, Ophthalmology, Others | General Surgery | Cosmetic |
Competitive Landscape and Market Positioning
1. Johnson & Johnson (United States)
2. Medtronic plc (Ireland)
3. Baxter International Inc. (United States)
4. Becton Dickinson and Company (United States)
5. B. Braun SE (Germany)
6. Terumo Corporation (Japan)
7. Integra LifeSciences Holdings Corporation (United States)
8. Stryker Corporation (United States)
9. Artivion Inc. (United States)
10. Cardinal Health Inc. (United States)
The surgical sealants and adhesives market is advancing through innovations in wound closure and tissue bonding technologies. Development efforts focus on improving biocompatibility and adhesion strength. The surgical sealants and adhesives market is also shaped by demand for minimally invasive surgical solutions. Continuous material innovation is enhancing procedural effectiveness.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| B. Braun SE | Sep-25 | B. Braun SE acquired True Digital Surgery (TDS), a Goleta-based developer of robotic-assisted 3D surgical microscopy systems, to strengthen its Aesculap AEOS platform and expand capabilities in digital microsurgery. The acquisition enhances its positioning across neurosurgery, spine, and ENT applications while establishing TDS as an innovation hub supporting advanced surgical visualization and precision procedures. |
| NAMSA | Oct-24 | NAMSA entered a strategic outsourcing partnership with Terumo to accelerate regulatory approval and commercialization of Terumo’s medical device portfolio. The collaboration leverages NAMSA’s clinical testing and regulatory expertise to streamline product development timelines, reduce costs, and improve global market access for surgical and interventional technologies. |
| Ethicon (Johnson & Johnson) | Nov-23 | Ethicon launched Ethizia, a hemostatic sealing patch designed to control surgical bleeding during procedures. The product strengthens Johnson & Johnson’s surgical portfolio in hemostats and sealing technologies, supporting improved intraoperative bleeding management across multiple surgical specialties and reinforcing its competitive position in advanced wound and tissue management solutions. |
| Pramand LLC | Nov-23 | Pramand LLC introduced the CraniSeal Dural Sealant System in the U.S. market for use in cranial surgery. The launch expands surgical closure options for neurosurgical procedures, addressing cerebrospinal fluid leakage prevention and reinforcing adoption of advanced dural sealing technologies in high-precision cranial interventions. |
| Animus Surgical | Mar-23 | Animus Surgical launched a transparent, biodegradable, non-toxic hydrogel wound sealant designed for surgical applications. The product contributes to the expansion of bioresorbable sealing technologies in wound closure, supporting improved biocompatibility and reducing reliance on traditional synthetic adhesives in surgical environments. |
| Baxter | 2018 | Baxter acquired two surgical hemostat and sealant products from Mallinckrodt, including RECOTHROM Thrombin topical hemostat and PREVELEAK surgical sealant. The acquisition strengthened Baxter’s portfolio in vascular reconstruction and surgical bleeding management, enhancing its competitive positioning in high-margin surgical sealants and adhesives applications. |
| Baxter | 2018 | Baxter launched a disposable curved applicator for its FLOSEAL Hemostatic Matrix product line, improving delivery efficiency in otolaryngology and head & neck surgical procedures. The innovation enhances usability and precision in intraoperative bleeding control, supporting broader adoption of hemostatic sealant technologies. |
| AMS | 2019 | AMS acquired Sealantis, an Israeli medical device company with an alga-mimetic sealant technology platform. The acquisition expands AMS’s surgical sealant capabilities and strengthens its pipeline of innovative internal surgery solutions, enhancing its position in high-growth minimally invasive and advanced tissue sealing applications. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Surgical Sealants and Adhesives Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Surgical Sealants and Adhesives Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchWhat is the market valuation of surgical sealants and adhesives?
How much is the surgical sealants and adhesives industry expected to grow by 2035?
How are rising surgical procedure volumes influencing adoption of sealants and adhesives?
How are advancements in biological adhesives impacting surgical safety and wound management outcomes?
Why do Natural or Biological Adhesives and Sealants hold the largest market share?
Why is Tissue Engineering the fastest-growing indication in the surgical sealants and adhesives market?
Why does North America hold the largest share of the surgical sealants and adhesives market?
What is fueling growth in the Asia Pacific surgical sealants and adhesives market?
Which companies dominate the surgical sealants and adhesives landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization